Company news

ASEP Medical Holdings Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Asep Medical Announces $288,500 Debt Settlement

September 18, 2026

Asep Medical Announces Cease Trade Order

May 6, 2026

Asep Medical Announces Closing of Private Placement of Convertible Debentures and Corporate Update

May 1, 2026

Asep Medical Announces Offering of Convertible Debentures and Closing of Debt Settlement

April 29, 2026

Asep Medical Announces $1,056,872 Debt Settlement

March 20, 2026

Offering document under the listed issuer financing exemption

March 6, 2026

Asep Medical Announces up to C$1,165,000 LIFE Offering

March 3, 2026

Asep Medical appoints Dr. Richard Heinzl as interim CEO

February 27, 2026

Asep Medical Announces Leadership Transition

February 20, 2026

Amends and Refiles its Management’s Discussion & Analysis for its Year Ended December 31, 2024

December 11, 2025

Licenses its Anti-Biofilm Technology to Bondent Group for Oral Rinse Development and Commercialization in China

November 10, 2025

Asep Medical Raises 5 Million RMB Through the Sale of a 10% Stake in Chinese Joint Venture

September 12, 2025

Validates its SepsetER Diagnostic Test in Patients in Leading Scientific Journal, Nature Communications.

May 26, 2025

Asep Medical Announces Proposed Share Consolidation

April 11, 2025

Asep Medical Announces $1,343,699 Debt Settlement

April 1, 2025

Asep Medical Announces $440,585 Debt Settlement

February 15, 2025

Asep Medical Confirms the Use of AI - Enables Improved Treatments for Common Biofilm Infections and Rapid Sepsis Diagnostics

March 13, 2024

Decks